Target type: biologicalprocess
Any process that activates or increases the frequency, rate, or extent of production of macrophage inflammatory protein 1 alpha. [GOC:mah]
Positive regulation of macrophage inflammatory protein 1 alpha (MIP-1α) production is a complex biological process involving multiple signaling pathways and cellular interactions. It is a key component of the innate immune response, mediating the recruitment and activation of immune cells to sites of inflammation and infection.
**Signal Transduction Pathways:**
* **TLR Signaling:** Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) on microbes, triggering downstream signaling pathways that activate transcription factors like NF-κB and AP-1. These factors promote the transcription of MIP-1α.
* **TNF-α Signaling:** Tumor necrosis factor-alpha (TNF-α) binds to its receptor, initiating a signaling cascade that activates NF-κB and MAP kinases, leading to increased MIP-1α production.
* **IFN-γ Signaling:** Interferon-gamma (IFN-γ) activates STAT1, a transcription factor that promotes MIP-1α expression.
* **IL-1β Signaling:** Interleukin-1 beta (IL-1β) activates NF-κB and MAP kinases, contributing to MIP-1α production.
**Cellular Interactions:**
* **Macrophages:** Macrophages are the primary producers of MIP-1α. Upon activation by pathogens, they release MIP-1α, which acts as a chemoattractant for other immune cells.
* **Dendritic Cells:** Dendritic cells, another type of immune cell, can produce MIP-1α, further contributing to the inflammatory response.
* **T Cells:** T cells, especially CD4+ T cells, can also produce MIP-1α, amplifying the immune response.
**Molecular Mechanisms:**
* **Transcriptional Regulation:** The MIP-1α gene is transcribed by RNA polymerase II, and its expression is regulated by the binding of transcription factors like NF-κB, AP-1, and STAT1 to the promoter region.
* **Post-transcriptional Regulation:** MIP-1α mRNA can undergo post-transcriptional regulation, such as alternative splicing and mRNA stability, which influence its abundance and translation.
* **Post-translational Regulation:** MIP-1α protein can be post-translationally modified, such as by glycosylation, affecting its stability and activity.
**Biological Significance:**
* **Immune Cell Recruitment:** MIP-1α acts as a potent chemoattractant for monocytes, neutrophils, and lymphocytes, contributing to the accumulation of immune cells at sites of inflammation.
* **Inflammation:** MIP-1α plays a critical role in inflammation, promoting the activation and differentiation of immune cells.
* **Anti-viral and Anti-bacterial Immunity:** MIP-1α contributes to the host defense against viral and bacterial infections by promoting the recruitment and activation of immune cells.
**Conclusion:**
Positive regulation of MIP-1α production is a tightly controlled and complex process that is essential for the initiation and development of the inflammatory response. Dysregulation of MIP-1α production is linked to various inflammatory diseases, making it a potential therapeutic target.'
"
Protein | Definition | Taxonomy |
---|---|---|
Transient receptor potential cation channel subfamily V member 4 | A transient receptor potential cation channel TRPV4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9HBA0] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
cannabinol | Cannabinol: A physiologically inactive constituent of Cannabis sativa L. | dibenzopyran | |
cannabichromene | 1-benzopyran | ||
(6ar-trans)-isomer of tetrahydrocannabivarin 9 | |||
hc 030031 | 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide: a TRPA1 channel blocker | ||
hc-067047 | HC-067047: a TRPA1 antagonist; structure in first source | ||
rn 1734 | RN 1734: a TRPV4 antagonist; structure in first source | ||
cannabigerol | cannabigerol : A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. cannabigerol: RN given refers to (E)-isomer; structure given in first source | phytocannabinoid; resorcinols | anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite |
cannabidivarin | cannabidivarin: from Cannabis sativa | monoterpenoid | |
gsk 1016790a | GSK1016790A : A tertiary carboxamide that is piperazine in which one of the amino groups has undergone condensation with the carboxy group of N-[(2,4-dichlorophenyl)sulfonyl]-L-serine, while the other has undergone condensation with the carboxy group of N-(1-benzothiophen-2-ylcarbonyl)-L-leucine. It is a cell-permeable, potent and selective agonist of the TRPV4 (transient receptor potential vanilloid 4) channel. | 1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide | TRPV4 agonist |